关注
MING-LUNG YU
MING-LUNG YU
在 kmu.edu.tw 的电子邮件经过验证
标题
引用次数
引用次数
年份
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13247*2021
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
SM Lin, ML Yu, CM Lee, RN Chien, IS Sheen, CM Chu, YF Liaw
Journal of hepatology 46 (1), 45-52, 2007
4882007
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
ML Yu, CY Dai, JF Huang, NJ Hou, LP Lee, MY Hsieh, CF Chiu, ZY Lin, ...
Gut 56 (4), 553-559, 2007
3622007
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial
ML Yu, CY Dai, JF Huang, CF Chiu, YHC Yang, NJ Hou, LP Lee, ...
Hepatology 47 (6), 1884-1893, 2008
3422008
Treatment of chronic hepatitis C in Asia: when East meets West.
ML Yu, WL Chuang
Journal of Gastroenterology & Hepatology 24 (3), 2009
3402009
APASL consensus statements and recommendation on treatment of hepatitis C
M Omata, T Kanda, L Wei, ML Yu, WL Chuang, A Ibrahim, CRA Lesmana, ...
Hepatology international 10, 702-726, 2016
2432016
APASL consensus statements and management algorithms for hepatitis C virus infection
M Omata, T Kanda, ML Yu, O Yokosuka, SG Lim, W Jafri, R Tateishi, ...
Hepatology International 6, 409-435, 2012
2382012
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
CJ Liu, WL Chuang, CM Lee, ML Yu, SN Lu, SS Wu, LY Liao, CL Chen, ...
Gastroenterology 136 (2), 496-504. e3, 2009
2302009
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre …
ML Yu, SM Lin, WL Chuang, CY Dai, JH Wang, SN Lu, IS Sheen, ...
Antiviral therapy 11 (8), 985-994, 2006
2292006
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
ML Yu, CF Huang, JF Huang, NC Chang, JF Yang, ZY Lin, SC Chen, ...
Hepatology 53 (1), 7-13, 2011
2162011
Significant correlations between severe fatty liver and risk factors for metabolic syndrome
PJ Hsiao, KK Kuo, SJ Shin, YH Yang, WY Lin, JF Yang, CC Chiu, ...
Journal of gastroenterology and hepatology 22 (12), 2118-2123, 2007
1942007
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
CW Lin, CC Lin, LR Mo, CY Chang, DS Perng, CC Hsu, GH Lo, YS Chen, ...
Journal of hepatology 58 (4), 730-735, 2013
1912013
Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition
S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ...
Cancer cell 30 (6), 879-890, 2016
1872016
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
CY Dai, JF Huang, MY Hsieh, NJ Hou, ZY Lin, SC Chen, MY Hsieh, ...
Journal of hepatology 50 (4), 712-718, 2009
1822009
Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis
MM Mücke, LI Backus, VT Mücke, N Coppola, CM Preda, ML Yeh, ...
The Lancet Gastroenterology & Hepatology 3 (3), 172-180, 2018
1792018
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study
CY Dai, WL Chuang, CK Ho, MY Hsieh, JF Huang, LP Lee, NJ Hou, ...
Journal of hepatology 49 (1), 9-16, 2008
1792008
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1762022
Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication
JF Huang, CY Dai, SJ Hwang, CK Ho, PJ Hsiao, MY Hsieh, LP Lee, ...
Official journal of the American College of Gastroenterology| ACG 102 (6 …, 2007
1682007
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
GLH Wong, VWS Wong, A Thompson, J Jia, J Hou, CRA Lesmana, ...
The Lancet Gastroenterology & Hepatology 5 (8), 776-787, 2020
1532020
Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis
JJ Lee, MY Lin, JS Chang, CC Hung, JM Chang, HC Chen, ML Yu, ...
PloS one 9 (6), e100790, 2014
1422014
系统目前无法执行此操作,请稍后再试。
文章 1–20